These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8930405

  • 1. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
    Huynh DP, Tran TM, Nechiporuk T, Pulst SM.
    Cell Growth Differ; 1996 Nov; 7(11):1551-61. PubMed ID: 8930405
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.
    Akhmametyeva EM, Mihaylova MM, Luo H, Kharzai S, Welling DB, Chang LS.
    Dev Dyn; 2006 Oct; 235(10):2771-85. PubMed ID: 16894610
    [Abstract] [Full Text] [Related]

  • 3. [Neurofibromatosis type 2 (NF2)].
    Araki N, Takeshima H, Saya H.
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [Abstract] [Full Text] [Related]

  • 4. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
    Chen Y, Gutmann DH, Haipek CA, Martinsen BJ, Bronner-Fraser M, Krull CE.
    Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
    [Abstract] [Full Text] [Related]

  • 5. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
    Huynh DP, Pulst SM.
    Oncogene; 1996 Jul 04; 13(1):73-84. PubMed ID: 8700556
    [Abstract] [Full Text] [Related]

  • 6. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
    Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJ, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR.
    Nat Genet; 1994 Feb 04; 6(2):185-92. PubMed ID: 8162073
    [Abstract] [Full Text] [Related]

  • 7. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
    Lutchman M, Rouleau GA.
    Cancer Res; 1995 Jun 01; 55(11):2270-4. PubMed ID: 7757975
    [Abstract] [Full Text] [Related]

  • 8. NF2: the wizardry of merlin.
    Xiao GH, Chernoff J, Testa JR.
    Genes Chromosomes Cancer; 2003 Dec 01; 38(4):389-99. PubMed ID: 14566860
    [Abstract] [Full Text] [Related]

  • 9. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR, Huynh DP, Morcos PA, Coulsell ER, Robinson NG, Tamanoi F, Pulst SM.
    Nat Genet; 1998 Apr 01; 18(4):354-9. PubMed ID: 9537418
    [Abstract] [Full Text] [Related]

  • 10. Expression pattern of BM88 in the developing nervous system of the chick and mouse embryo.
    Politis PK, Rohrer H, Matsas R.
    Gene Expr Patterns; 2007 Jan 01; 7(1-2):165-77. PubMed ID: 16949349
    [Abstract] [Full Text] [Related]

  • 11. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H, Araki N, Takeshima H, Nishi T, Hirota T, Kimura Y, Nakao M, Saya H.
    Oncogene; 1998 Aug 20; 17(7):801-10. PubMed ID: 9779996
    [Abstract] [Full Text] [Related]

  • 12. Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains.
    Huynh DP, Nechiporuk T, Pulst SM.
    Hum Mol Genet; 1994 Jul 20; 3(7):1075-9. PubMed ID: 7981675
    [Abstract] [Full Text] [Related]

  • 13. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L, Xu HM, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P, Gutmann DH.
    Oncogene; 1997 Nov 13; 15(20):2505-9. PubMed ID: 9395247
    [Abstract] [Full Text] [Related]

  • 14. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM, Kaye AH.
    J Clin Neurosci; 2001 Jan 13; 8(1):4-7. PubMed ID: 11148074
    [Abstract] [Full Text] [Related]

  • 15. Deposition of collagen VI in the extracellular matrix during mouse embryogenesis correlates with expression of the alpha 3(VI) subunit gene.
    Dziadek M, Darling P, Bakker M, Overall M, Zhang RZ, Pan TC, Tillet E, Timpl R, Chu ML.
    Exp Cell Res; 1996 Aug 01; 226(2):302-15. PubMed ID: 8806434
    [Abstract] [Full Text] [Related]

  • 16. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ, Surace EI, Cambell M, Higgins RJ, Leutenegger CM, Bollen AW, LeCouteur RA, Gutmann DH.
    Vet Pathol; 2009 Sep 01; 46(5):884-92. PubMed ID: 19429976
    [Abstract] [Full Text] [Related]

  • 17. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N, Seizinger BR.
    Cancer Surv; 1995 Sep 01; 25():207-18. PubMed ID: 8718520
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the neurofibromatosis 2 gene in human breast and hepatocellular carcinomas.
    Kanai Y, Tsuda H, Oda T, Sakamoto M, Hirohashi S.
    Jpn J Clin Oncol; 1995 Feb 01; 25(1):1-4. PubMed ID: 7877257
    [Abstract] [Full Text] [Related]

  • 19. A point mutation associated with a severe phenotype of neurofibromatosis 2.
    MacCollin M, Braverman N, Viskochil D, Ruttledge M, Davis K, Ojemann R, Gusella J, Parry DM.
    Ann Neurol; 1996 Sep 01; 40(3):440-5. PubMed ID: 8797533
    [Abstract] [Full Text] [Related]

  • 20. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
    Stemmer-Rachamimov AO, Gonzalez-Agosti C, Xu L, Burwick JA, Beauchamp R, Pinney D, Louis DN, Ramesh V.
    J Neuropathol Exp Neurol; 1997 Jun 01; 56(6):735-42. PubMed ID: 9184664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.